Lista de obras -

A New Era of Oral Anticoagulation in Atrial Fibrillation: Implications in Clinical Practice ⬇️

artículo científico publicado el 1 de febrero de 2013

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants

scientific article published on 30 June 2013

Angiopoietins and preeclampsia: new perspectives in the quest for markers

artículo científico publicado en 2009

Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis.

artículo científico publicado en 2010

Antiplatelet Therapy in Stroke Prevention ⬇️

artículo científico publicado el 9 de agosto de 2012

Apical hypertrophic cardiomyopathy associated with multiple coronary artery-left ventricular fistulae: a report of a case and review of the literature

artículo científico publicado en 2009

Aspirin and aspirin resistance in coronary artery disease ⬇️

artículo científico publicado el 5 de enero de 2013

Atrial fibrillation (acute onset)

scientific article published on 15 February 2011

Atrial fibrillation (acute onset)

scientific article published on 27 November 2014

Atrial fibrillation (chronic)

scientific article published on 10 November 2011

Bleeding Risk Assessment in Patients With Atrial Fibrillation Who Are Taking Oral Anticoagulants ⬇️

artículo científico publicado el 1 de febrero de 2013

Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement

artículo científico publicado el 1 de enero de 2012

Bridging Evidence-Based Practice and Practice-Based Evidence in Periprocedural Anticoagulation ⬇️

artículo científico publicado el 25 de septiembre de 2012

Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation

artículo científico publicado en 2012

Bridging therapy: a challenging area in the management of patients with atrial fibrillation

artículo científico publicado en 2013

British Society of Echocardiography Departmental Accreditation Standards 2019 with input from the Intensive Care Society

scientific article published on 17 February 2020

CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators

artículo científico publicado en 2007

Catheter-related septic thrombophlebitis of the superior vena cava involving the atrial septum: a case report

artículo científico publicado en 2008

Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway.

artículo científico

Chemokines in respiratory viral infections: focus on their diagnostic and therapeutic potential

artículo científico

Chemokines in vascular pathology (review).

artículo científico publicado en 2006

Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".

artículo científico publicado en 2009

Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants

artículo científico publicado en 2013

Desmoteplase as a potential treatment for cerebral ischaemia.

artículo científico

Detection of cytomegalovirus in atherosclerotic plaques and nonatherosclerotic arteries.

artículo científico publicado en 2008

Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study

artículo científico publicado en 2013

Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice

artículo científico publicado en 2013

Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease

artículo científico publicado en 2006

Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease ⬇️

artículo científico publicado el 28 de marzo de 2011

Evidence guided antiplatelet treatment: time to move from bench to bedside.

artículo científico publicado en 2009

Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease

artículo científico

Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score

artículo científico publicado en 2013

Fibrinolytic status in acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways

scientific article published on 27 April 2012

Flecainide acetate for the treatment of atrial and ventricular arrhythmias

artículo científico publicado en 2013

Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis.

artículo científico publicado en 2009

Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.

artículo científico publicado en 2009

Genetic diversity of the KCNE1 gene and susceptibility to postoperative atrial fibrillation

artículo científico publicado en 2014

Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection

artículo científico publicado en 2009

Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery disease

artículo científico publicado en 2010

Homocysteine and metalloprotease-3 and -9 in patients with ascending aorta aneurysms

artículo científico publicado en 2011

Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial

artículo científico publicado en 2014

How early is early enough to prevent stroke in atrial fibrillation?

artículo científico publicado en 2012

IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications

artículo científico publicado en 2008

Iatrogenic right coronary artery dissection distal to a total occlusion: a case report

artículo científico publicado en 2009

Inflammation in atrial fibrillation

artículo científico publicado en 2012

Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism

artículo científico publicado en 2015

Interleukin 8 and cardiovascular disease

scientific article published on 18 July 2009

Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective.

artículo científico publicado en 2008

Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention.

artículo científico publicado en 2010

Left ventricular geometry and outcomes in patients with atrial fibrillation: the AFFIRM Trial

artículo científico publicado en 2013

Letter by Apostolakis et al regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direc

artículo científico publicado en 2013

Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy

artículo científico publicado en 2011

Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial

artículo científico publicado en 2013

Lymphocutaneous nocardiosis in a lymphopenic breast cancer patient under treatment with docetaxel

artículo científico publicado en 2005

Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis

artículo científico publicado en 2014

Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?

artículo científico publicado en 2009

New anticoagulant treatments to protect against stroke in atrial fibrillation

artículo científico

New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?

artículo científico publicado en 2009

New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation ⬇️

artículo científico publicado el 1 de diciembre de 2012

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban ⬇️

artículo científico publicado el 23 de mayo de 2012

Opposite effect of angiotensin receptor blockade on CXCL8 production and CXCR1/2 expression of angiotensin II-treated THP-1 monocytes

artículo científico publicado en 2013

Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients

artículo científico publicado en 2012

Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with

artículo científico publicado en 2012

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

artículo científico publicado en 2013

Pharmacokinetic considerations for antithrombotic therapies in stroke

artículo científico

RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis

artículo científico publicado en 2008

Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial

artículo científico publicado en 2013

Reply: To PMID 22858389.

artículo científico publicado en 2013

Response

Response to Letter Regarding Article, “Bridging Evidence-Based Practice and Practice-Based Evidence in Periprocedural Anticoagulation” ⬇️

artículo científico publicado el 14 de mayo de 2013

Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications.

artículo científico publicado en 2007

Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact? ⬇️

artículo científico publicado el 23 de octubre de 2012

Stroke-complicated endocarditis with positive lupus anticoagulant--a case report

scientific article published on 01 July 2005

T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.

artículo científico publicado en 2006

The Challenge of Antiplatelet Therapy in Patients with Atrial Fibrillation and Heart Failure ⬇️

artículo científico publicado el 4 de diciembre de 2012

The Emerging Role of Biomarkers in Atrial Fibrillation ⬇️

artículo científico publicado el 17 de agosto de 2013

The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review

artículo científico publicado en 2014

The quest for new anticoagulants: from clinical development to clinical practice

artículo científico publicado en 2010

The right ventricle in health and disease: insights into physiology, pathophysiology and diagnostic management

artículo científico publicado en 2012

The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia ⬇️

artículo científico publicado el 1 de julio de 2012

Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias

artículo científico publicado en 2010

Transcriptional regulation of TIMPs in ascending aorta aneurysms.

artículo científico publicado en 2010

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation

artículo científico publicado en 2012

Vascular imaging as a cardiovascular risk stratification tool in systemic lupus erythematosus

artículo científico publicado en 2009

Lista de obras de

A New Era of Oral Anticoagulation in Atrial Fibrillation: Implications in Clinical Practice ⬇️

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants

Angiopoietins and preeclampsia: new perspectives in the quest for markers

Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis.

Antiplatelet Therapy in Stroke Prevention ⬇️

Apical hypertrophic cardiomyopathy associated with multiple coronary artery-left ventricular fistulae: a report of a case and review of the literature

Aspirin and aspirin resistance in coronary artery disease ⬇️

Atrial fibrillation (acute onset)

Atrial fibrillation (acute onset)

Atrial fibrillation (chronic)

Bleeding Risk Assessment in Patients With Atrial Fibrillation Who Are Taking Oral Anticoagulants ⬇️

Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement

Bridging Evidence-Based Practice and Practice-Based Evidence in Periprocedural Anticoagulation ⬇️

Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation

Bridging therapy: a challenging area in the management of patients with atrial fibrillation

British Society of Echocardiography Departmental Accreditation Standards 2019 with input from the Intensive Care Society

CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators

Catheter-related septic thrombophlebitis of the superior vena cava involving the atrial septum: a case report

Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway.

Chemokines in respiratory viral infections: focus on their diagnostic and therapeutic potential

Chemokines in vascular pathology (review).

Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".

Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants

Desmoteplase as a potential treatment for cerebral ischaemia.

Detection of cytomegalovirus in atherosclerotic plaques and nonatherosclerotic arteries.

Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study

Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice

Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease

Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease ⬇️

Evidence guided antiplatelet treatment: time to move from bench to bedside.

Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease

Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score

Fibrinolytic status in acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways

Flecainide acetate for the treatment of atrial and ventricular arrhythmias

Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis.

Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.

Genetic diversity of the KCNE1 gene and susceptibility to postoperative atrial fibrillation

Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection

Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery disease

Homocysteine and metalloprotease-3 and -9 in patients with ascending aorta aneurysms

Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial

How early is early enough to prevent stroke in atrial fibrillation?

IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications

Iatrogenic right coronary artery dissection distal to a total occlusion: a case report

Inflammation in atrial fibrillation

Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism

Interleukin 8 and cardiovascular disease

Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective.

Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention.

Left ventricular geometry and outcomes in patients with atrial fibrillation: the AFFIRM Trial

Letter by Apostolakis et al regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direc

Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy

Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial

Lymphocutaneous nocardiosis in a lymphopenic breast cancer patient under treatment with docetaxel

Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis

Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?

New anticoagulant treatments to protect against stroke in atrial fibrillation

New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?

New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation ⬇️

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban ⬇️

Opposite effect of angiotensin receptor blockade on CXCL8 production and CXCR1/2 expression of angiotensin II-treated THP-1 monocytes

Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients

Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Pharmacokinetic considerations for antithrombotic therapies in stroke

RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis

Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial

Reply: To PMID 22858389.

Response

Response

Response to Letter Regarding Article, “Bridging Evidence-Based Practice and Practice-Based Evidence in Periprocedural Anticoagulation” ⬇️

Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications.

Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact? ⬇️

Stroke-complicated endocarditis with positive lupus anticoagulant--a case report

T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.

The Challenge of Antiplatelet Therapy in Patients with Atrial Fibrillation and Heart Failure ⬇️

The Emerging Role of Biomarkers in Atrial Fibrillation ⬇️

The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review

The quest for new anticoagulants: from clinical development to clinical practice